NasdaqCM - Delayed Quote USD

Revelation Biosciences, Inc. (REVB)

2.2000 -0.0700 (-3.08%)
At close: June 7 at 4:00 PM EDT
2.1800 -0.02 (-0.91%)
After hours: June 7 at 7:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
8,938.9550
8,656.6640
10,864.5110
11,950.4850
Operating Income
-8,938.9550
-8,656.6640
-10,864.5110
-11,950.4850
Other Income Expense
-21.9270
8,536.4100
34.9620
-36.3520
Pretax Income
-8,960.8820
-120.2540
-10,829.5490
-11,986.8370
Net Income Common Stockholders
-8,960.8820
-120.2540
-10,829.5490
-11,986.8370
Diluted NI Available to Com Stockholders
-8,960.8820
-120.2540
-10,829.5490
-11,986.8370
Basic EPS
-48.51
-0.53
-149.20
-972.41
Diluted EPS
-48.51
-0.53
-149.20
-972.41
Basic Average Shares
467.2720
228.6400
72.5850
12.3270
Diluted Average Shares
467.2720
228.6400
72.5850
12.3270
Total Operating Income as Reported
-8,938.9550
-8,656.6640
-10,864.5110
-11,950.4850
Total Expenses
8,938.9550
8,656.6640
10,864.5110
11,950.4850
Net Income from Continuing & Discontinued Operation
-8,960.8820
-120.2540
-10,829.5490
-11,986.8370
Normalized Income
-9,613.3110
-8,449.1910
-10,829.5490
-11,986.8370
EBIT
-8,938.9550
-8,656.6640
-10,864.5110
-11,950.4850
EBITDA
-8,913.9070
-8,631.6150
-10,839.4630
-11,933.7030
Reconciled Depreciation
25.0480
25.0490
25.0480
16.7820
Net Income from Continuing Operation Net Minority Interest
-8,960.8820
-120.2540
-10,829.5490
-11,986.8370
Total Unusual Items Excluding Goodwill
652.4290
8,328.9370
--
--
Total Unusual Items
652.4290
8,328.9370
--
--
Normalized EBITDA
-9,566.3360
-16,960.5520
-10,839.4630
-11,933.7030
12/31/2021 - 11/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QNRX Quoin Pharmaceuticals, Ltd.
0.7200
-1.37%
 
ENSC Ensysce Biosciences, Inc.
0.5455
+0.06%
 
PBLA Panbela Therapeutics, Inc.
0.3701
-3.12%
 
ZVSA ZyVersa Therapeutics, Inc.
4.4100
-6.96%
 
KPRX Kiora Pharmaceuticals, Inc.
0.4700
+8.80%
 
TENX Tenax Therapeutics, Inc.
3.4500
-2.54%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7000
+2.41%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.9300
-1.26%
 
AZTR Azitra, Inc.
0.1496
-9.39%
 
DRMA Dermata Therapeutics, Inc.
3.3000
-5.44%